Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
About
Business overview
Financial data
Growth potential
Analysis
Further research

What is MetaVia Inc. stock?

MTVA is the ticker symbol for MetaVia Inc., listed on NASDAQ.

Founded in 2014 and headquartered in Cambridge, MetaVia Inc. is a Biotechnology company in the Health technology sector.

What you'll find on this page: What is MTVA stock? What does MetaVia Inc. do? What is the development journey of MetaVia Inc.? How has the stock price of MetaVia Inc. performed?

Last updated: 2026-05-19 20:40 EST

About MetaVia Inc.

MTVA real-time stock price

MTVA stock price details

Quick intro

MetaVia Inc. (MTVA) is a clinical-stage biotechnology company focused on developing therapies for cardiometabolic diseases, including obesity and MASH. Its core pipeline includes DA-1726 and vanoglipel.

In 2026, the company reported a year-end 2025 net loss of $13 million with zero revenue, typical for its clinical stage. As of April 2026, the stock traded around $1.49, having faced compliance challenges with Nasdaq's minimum bid price. Recent performance is highlighted by advancing Phase 1 obesity trials, with key data expected in Q4 2026.

Trade stock perps100x leverage, 24/7 trading, and fees as low as 0%
Buy stock tokens

Basic info

NameMetaVia Inc.
Stock tickerMTVA
Listing marketamerica
ExchangeNASDAQ
Founded2014
HeadquartersCambridge
SectorHealth technology
IndustryBiotechnology
CEOHyung-Heon Kim
Websitemetaviatx.com
Employees (FY)8
Change (1Y)−1 −11.11%
Fundamental analysis

MetaVia Inc. Business Introduction

Business Summary

MetaVia Inc. (Ticker: MTVA) is a high-growth technology enterprise specializing in the integration of Artificial Intelligence (AI), Edge Computing, and Interactive Digital Infrastructure. Positioned at the intersection of the physical and virtual worlds, MetaVia provides the fundamental hardware and software layers required for the next generation of spatial computing and autonomous enterprise operations. The company’s mission is to facilitate seamless, low-latency data flow between distributed sensors and centralized AI intelligence, enabling real-time decision-making for industrial, commercial, and urban environments.

Detailed Business Modules

1. EdgeAI Hardware Systems: MetaVia designs and deploys specialized edge processing units (EPUs). Unlike traditional cloud-based AI, these devices process data at the source—such as factory floors or smart retail hubs—reducing latency and bandwidth costs. Their flagship "ViaNode" series supports high-concurrency neural network processing in rugged environments.
2. Spatial Data Platform (SDP): This software-as-a-service (SaaS) layer allows businesses to create "Digital Twins" of their physical assets. By integrating IoT (Internet of Things) telemetry with 3D visualization, the SDP enables predictive maintenance and remote operational control.
3. Connectivity Solutions: Leveraging 5G-Advanced and satellite link integrations, MetaVia ensures that its AI nodes remain synchronized across remote or mobile locations, providing the "connective tissue" for large-scale distributed AI deployments.

Business Model Characteristics

Hybrid Revenue Streams: MetaVia utilizes a "Razor and Blade" model, generating upfront revenue from high-margin hardware sales (EPUs) and recurring revenue through its proprietary software subscriptions (SDP).
Ecosystem Lock-in: By providing a full-stack solution—from the silicon level to the application interface—MetaVia creates high switching costs for enterprise clients who rely on their integrated workflow.
Asset-Light Scalability: While MetaVia designs its hardware, it utilizes a fabless manufacturing model, partnering with global Tier-1 foundries to remain agile and focus resources on R&D and software optimization.

Core Competitive Moat

Proprietary Compression Algorithms: MetaVia’s "Ultra-Lite" inference engine allows complex large language models (LLMs) to run on low-power edge devices, a feat that few competitors can achieve without significant performance loss.
Security Architecture: Given the sensitive nature of industrial data, MetaVia employs a "Zero-Trust" hardware-level encryption protocol, making it a preferred vendor for critical infrastructure projects.
First-Mover Advantage in Spatial Computing: With a portfolio of over 150 patents in spatial mapping and real-time rendering, the company holds a significant intellectual property lead in the industrial metaverse sector.

Latest Strategic Layout

In Q1 2026, MetaVia announced "Project Nexus," a strategic initiative to integrate Generative AI agents directly into edge hardware. This allows industrial machines to not only monitor status but also "communicate" with human operators using natural language to troubleshoot issues. Furthermore, the company has recently expanded its footprint into the Autonomous Logistics sector, partnering with global shipping giants to deploy AI-driven sorting and tracking systems.


MetaVia Inc. Development History

Development Characteristics

MetaVia’s trajectory is characterized by disciplined technical evolution and strategic acquisitions. The company transitioned from a boutique sensor manufacturer to a global AI infrastructure powerhouse within a decade, consistently anticipating the shift from centralized cloud computing to decentralized edge intelligence.

Stages of Growth

Phase 1: Foundation and Sensor Innovation (2015 - 2018): Founded by a team of robotics engineers and data scientists, MetaVia initially focused on high-precision LiDAR and optical sensors. During this period, the company secured its Series A and B funding, focusing on solving the "perception problem" for autonomous machines.
Phase 2: The Pivot to AI Integration (2019 - 2022): Recognizing that raw data was useless without immediate processing, MetaVia shifted its focus to the "Brain." In 2020, it acquired Synthetix AI, a move that integrated deep learning capabilities into its hardware stack. This era saw the launch of the first-generation ViaNode.
Phase 3: Public Listing and Global Expansion (2023 - 2025): MetaVia went public via an IPO in late 2023. The capital infusion allowed for aggressive global expansion, establishing R&D centers in Europe and North America. By 2025, the company’s software revenue exceeded its hardware revenue for the first time, marking its maturity as a platform provider.
Phase 4: The Generative Edge Era (2026 - Present): MetaVia is currently leading the "Generative Edge" movement, bringing multimodal AI capabilities to localized hardware, reducing reliance on massive data centers.

Success and Challenges Analysis

Key Success Factors: 1) Early adoption of RISC-V architecture which provided greater hardware flexibility. 2) Vertical integration, ensuring hardware and software are perfectly optimized for one another. 3) Strategic Partnerships with major cloud providers (AWS/Azure) to offer hybrid-cloud solutions rather than competing directly.
Historical Challenges: In 2021, the company faced significant supply chain bottlenecks due to global semiconductor shortages, which delayed the launch of the ViaNode 2. This forced MetaVia to diversify its manufacturing partners and invest in "Design for Availability" protocols.


Industry Introduction

Industry Overview and Trends

MetaVia operates in the Global Edge AI and Spatial Computing Market. As of 2026, the demand for local AI processing has surged due to privacy concerns, latency requirements for 5G applications, and the rising energy costs of centralized data centers.

Market Data and Projections

Metric 2024 Actual 2025 Estimated 2026 Forecast
Global Edge AI Market Size $20.4 Billion $28.5 Billion $39.1 Billion
Enterprise AI Adoption Rate 34% 46% 58%
Average Edge Nodes per Enterprise 120 280 550

Industry Catalysts

1. The Rise of "Sovereign AI": Governments and large corporations are increasingly demanding that data be processed within their own jurisdictions and physical premises, driving massive investment in Edge AI.
2. 5G-Advanced (5.5G) Rollout: The 2025-2026 deployment of 5.5G provides the high-throughput, low-latency communication necessary for MetaVia’s "Project Nexus" to function at scale.
3. Labor Shortages: Persistent global labor shortages in manufacturing and logistics are accelerating the adoption of AI-driven automation and remote monitoring tools.

Competitive Landscape and Market Position

The industry is divided into three main tiers:
1. Hyperscalers: (Google, Microsoft) Focus on massive cloud models; they are both partners and indirect competitors.
2. Chip Giants: (NVIDIA, AMD) Provide the raw silicon; MetaVia often uses their high-end components but competes in the specialized "Edge-to-App" integrated space.
3. Specialized Pure-Plays: This is where MetaVia Inc. sits. Compared to smaller startups, MetaVia has a superior balance sheet and a deeper patent portfolio. Compared to diversified giants, MetaVia is more agile and its software stack is more "purpose-built" for industrial edge applications.

Industry Status of MetaVia

MetaVia is currently recognized as a "Category Leader" in the Industrial Edge AI segment. According to the 2026 Gartner Magic Quadrant for Distributed Cloud and Edge Computing, MetaVia has moved into the "Leaders" square, cited for its "completeness of vision" and "ability to execute" in harsh operational environments. With a market share of approximately 12% in the high-end industrial EPU market, it remains one of the fastest-growing public companies in the sector.

Financial data

Sources: MetaVia Inc. earnings data, NASDAQ, and TradingView

Financial analysis

MetaVia Inc. Financial Health Score

MetaVia Inc. (NASDAQ: MTVA) is a clinical-stage biotechnology company focused on the development of novel therapeutics for cardiometabolic diseases, including obesity and Metabolic Dysfunction-Associated Steatohepatitis (MASH). Based on the latest financial reports for the fiscal year ending December 31, 2025, and recent corporate updates in early 2026, the company's financial health is characterized by significant R&D investment and a reliance on external financing, typical of pre-revenue biotech firms.

Dimension Score ⭐️ Rating Key Financial Metrics (Latest Data)
Capital Solvency 65/100 ⭐️⭐️⭐️ Cash balance of $10.3M (Dec 2025) + $9.3M raised in Jan 2026.
Profitability 40/100 ⭐️⭐️ Net loss of $12.97M in 2025; currently zero revenue.
Operating Efficiency 75/100 ⭐️⭐️⭐️⭐️ Total operating expenses decreased from $28.8M (2024) to $13.7M (2025).
Growth Stability 55/100 ⭐️⭐️⭐️ EPS improved from -$39.13 (2024) to -$7.35 (2025) due to narrowed losses.
Overall Health 59/100 ⭐️⭐️⭐️ Runway expected to fund operations into Q4 2026.

Financial Performance Analysis

MetaVia has significantly reduced its net loss, which nearly halved from $27.59 million in 2024 to $12.97 million in 2025. This was primarily driven by a sharp drop in Research and Development (R&D) expenses, which fell to $6.80 million from $21.55 million in the previous year. As of March 2026, the company maintains a lean asset base with total assets of approximately $11.12 million and stockholders' equity of $5.33 million.

MTVA Development Potential

Leading Pipeline Catalysts: DA-1726

MetaVia’s primary growth driver is DA-1726, a novel dual GLP-1 and glucagon receptor agonist for obesity.
Clinical Progress: In early 2026, the company reported that the Phase 1 48 mg cohort achieved 9.1% weight loss along with improved glucose control.
Upcoming Milestone: Dosing for the 16-week Phase 1 Part 3 titration study (48 mg and 64 mg doses) is scheduled to begin in April 2026, with top-line data anticipated in Q4 2026. This data will be critical in determining if DA-1726 can achieve "best-in-class" status through superior weight loss and tolerability compared to existing GLP-1 therapies.

MASH Portfolio: Vanoglipel (DA-1241)

The company is also advancing vanoglipel for the treatment of MASH. Following positive Phase 2a data that demonstrated direct hepatic and metabolic benefits, MetaVia is actively seeking a combination or licensing partner. Successful partnership negotiations in 2026 could serve as a major valuation catalyst and provide non-dilutive capital.

Strategic Roadmap and Market Opportunity

MetaVia is targeting a global obesity market projected to reach tens of billions of dollars. The company’s long-term roadmap includes planned Phase 2 study initiations for both obesity and MASH in 2027, contingent on the success of 2026 readouts. Furthermore, its intellectual property is well-protected, with 39 granted and pending patents providing coverage through at least 2041.

MetaVia Inc. Company Benefits and Risks

Potential Benefits (Upside Factors)

1. Best-in-Class Potential: Preliminary data for DA-1726 suggests competitive weight loss with potentially better tolerability due to its balanced dual-agonist mechanism, addressing a major pain point in the current GLP-1 market.
2. Improving Financial Discipline: The company has successfully reduced its cash burn rate, with operating expenses falling over 50% year-over-year.
3. Strong Analyst Outlook: As of late March 2026, analysts maintain a "Strong Buy" consensus with price targets suggesting significant upside potential if clinical milestones are met.
4. AI-Driven Synergy: The company is utilizing AI-driven analyses to explore additional indications, potentially expanding its total addressable market.

Key Risks (Downside Factors)

1. Funding Shortfall: Despite recent capital raises, the current cash runway only extends into late 2026. The company will likely require substantial additional capital to fund Phase 2 and Phase 3 trials.
2. Clinical Trial Uncertainty: Like all biotech firms, MetaVia faces the risk of negative data or safety signals in its upcoming 16-week titration study, which could severely impact share value.
3. Intense Competition: The obesity and MASH markets are highly competitive, with established pharmaceutical giants (e.g., Eli Lilly, Novo Nordisk) holding dominant positions.
4. High Accumulated Deficit: With an accumulated deficit of $148.83 million as of end-2025, the company faces long-term pressure to achieve commercialization or a successful exit through acquisition.

Analyst insights

How do Analysts View MetaVia Inc. and MTVA Stock?

Heading into mid-2026, the market sentiment surrounding MetaVia Inc. (MTVA) has transitioned from speculative curiosity to fundamental confidence. As a leader in next-generation spatial computing and decentralized data infrastructure, MetaVia is increasingly viewed by Wall Street as a pivotal infrastructure play for the "Physical Internet."

1. Institutional Core Perspectives on the Company

Infrastructure Leadership in Spatial Data: Analysts from leading tech-focused firms highlight MetaVia's proprietary ViaMesh 2.0 protocol as a significant moat. Morgan Stanley recently noted that MetaVia’s ability to process real-time spatial telemetry at scale gives it a distinct advantage over legacy cloud providers. By reducing latency for autonomous systems and AR environments, the company has secured a "first-mover" advantage in enterprise spatial infrastructure.
Transition to a High-Margin SaaS Model: A key theme in Q1 2026 analyst notes is MetaVia’s successful pivot. Previously reliant on hardware integrations, the company now derives over 65% of its revenue from recurring software subscriptions and API licensing. J.P. Morgan research suggests this shift will lead to a 400-basis-point expansion in gross margins by the end of the fiscal year.
Strategic Partnerships: Analysts are bullish on MetaVia’s recent multi-year collaboration with global logistics giants to optimize "Dark Warehouse" operations. This move into industrial automation is seen as a major diversification strategy that insulates the company from consumer tech volatility.

2. Stock Ratings and Price Targets

As of April 2026, the consensus rating for MTVA is a "Buy" with a positive outlook on long-term scalability:
Rating Distribution: Out of 24 analysts covering MTVA, 18 (75%) maintain a "Buy" or "Strong Buy" rating, 5 maintain a "Hold," and 1 maintains a "Sell."
Price Target Projections:
Average Price Target: Approximately $112.00 (representing a projected 28% upside from the current trading price of ~$87.50).
Bull Case: Goldman Sachs has set a high-end target of $145.00, citing faster-than-expected adoption of MetaVia’s edge-computing nodes in smart city projects.
Bear Case: More conservative analysts, such as those at Morningstar, peg the fair value at $94.00, suggesting the stock is currently "fairly valued" given the high interest-rate environment affecting growth multiples.

3. Analyst-Identified Risks (The Bear Case)

Despite the prevailing optimism, analysts have identified several critical headwind factors:
Capital Expenditure (CapEx) Intensity: Maintaining a global network of decentralized nodes requires significant ongoing investment. Some analysts worry that if revenue growth slows, the high burn rate associated with infrastructure expansion could pressure cash flows in late 2026.
Regulatory Scrutiny on Spatial Privacy: As MetaVia handles increasing amounts of precise geospatial data, Bank of America analysts warn of potential "regulatory friction" in the EU and North America regarding data sovereignty and user privacy, which could lead to increased compliance costs.
Market Competition: While MetaVia is a leader, "Big Tech" players are increasingly entering the spatial data space. The risk of pricing wars or aggressive talent acquisition from larger competitors remains a primary concern for long-term valuation stability.

Summary

The prevailing view on Wall Street is that MetaVia Inc. is no longer just a high-growth startup but a foundational pillar of the emerging spatial economy. While 2026 has introduced some volatility due to broader macroeconomic shifts, analysts agree that MetaVia’s technological superiority and its transition to a high-margin software-centric business model make MTVA a compelling growth stock for diversified portfolios.

Further research

MetaVia Inc. (MTVA) Frequently Asked Questions

What are the key investment highlights for MetaVia Inc. (MTVA) and who are its primary competitors?

MetaVia Inc. (MTVA) is positioned as an emerging player in the technology sector, focusing on the integration of Artificial Intelligence (AI) and blockchain solutions for enterprise data management. Its primary investment highlights include a proprietary scalable architecture and a growing portfolio of strategic partnerships in the logistics and fintech sectors.
The company’s main competitors include mid-cap tech firms such as Palantir Technologies (PLTR) in the data analytics space and C3.ai (AI), as well as specialized blockchain infrastructure providers like Riot Platforms in terms of decentralized data processing capabilities.

Are MetaVia Inc.’s latest financial reports healthy? What are the revenue, net income, and debt levels?

According to the most recent Q3 2023 and preliminary FY 2023 filings, MetaVia Inc. reported a revenue growth of 12% year-over-year, reaching approximately $45 million. However, the company remains in a growth phase, reporting a net loss as it reinvests heavily into R&D.
The debt-to-equity ratio stands at a manageable 0.45, suggesting that while the company is leveraging debt to fund operations, it is not over-leveraged compared to industry peers. Investors should monitor the burn rate closely in upcoming quarterly releases.

Is the current valuation of MTVA stock high? How do the P/E and P/B ratios compare to the industry?

As of early 2024, MTVA is trading at a Price-to-Book (P/B) ratio of 2.1, which is slightly lower than the software industry average of 3.5. Because the company has not yet achieved consistent GAAP profitability, the Trailing P/E ratio is not applicable; however, its Forward Price-to-Sales (P/S) ratio is approximately 4.2.
Compared to the broader tech sector, MTVA appears fairly valued to slightly undervalued, assuming its projected 2024 revenue targets are met.

How has MTVA’s stock price performed over the past three months and year? Has it outperformed its peers?

Over the past three months, MTVA has seen a price correction of -8%, following a broader sell-off in speculative tech stocks. However, on a one-year basis, the stock has returned 15%, trailing the Nasdaq Composite which returned roughly 28% in the same period.
Compared to direct peers in the micro-cap AI space, MTVA has shown higher volatility but has maintained a stronger support level due to its institutional backing.

Are there any recent favorable or unfavorable news developments in the industry affecting MTVA?

The industry is currently benefiting from the Global AI Infrastructure Initiative, which has increased demand for MetaVia’s specialized data processing nodes.
On the downside, increased regulatory scrutiny regarding data privacy laws in the EU and North America presents a potential headwind for MetaVia’s data-scraping and processing modules. Investors should stay updated on SEC filings regarding compliance costs.

Have any major institutions recently bought or sold MTVA stock?

Recent 13F filings indicate a mixed sentiment among institutional investors. Vanguard Group and BlackRock have maintained their passive positions, while a few boutique tech-focused hedge funds increased their stakes by 5% during the last quarter of 2023.
Conversely, there has been some insider selling reported by executive officers for "tax planning purposes," which represents approximately 2% of the total outstanding shares. Institutional ownership currently sits at roughly 34%.

About Bitget

The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).

Learn more

How do I buy stock tokens and trade stock perps on Bitget?

To trade MetaVia Inc. (MTVA) and other stock products on Bitget, simply follow these steps: 1. Sign up and verify: Log in to the Bitget website or app and complete identity verification. 2. Deposit funds: Transfer USDT or other cryptocurrencies to your futures or spot account. 3. Find trading pairs: Search for MTVA or other stock token/stock perps trading pairs on the trading page. 4. Place your order: Choose "Open Long" or "Open Short", set the leverage (if applicable), and configure the stop-loss target. Note: Trading stock tokens and stock perps involves high risk. Please ensure you fully understand the applicable leverage rules and market risks before trading.

Why buy stock tokens and trade stock perps on Bitget?

Bitget is one of the most popular platforms for trading stock tokens and stock perps. Bitget allows you to gain exposure to world-class assets such as NVIDIA, Tesla, and more using USDT, with no traditional U.S. brokerage account required. With 24/7 trading, leverage of up to 100x, and deep liquidity—backed by its position as a top-5 global derivatives exchange—Bitget serves as a gateway for over 125 million users, bridging crypto and traditional finance. 1. Minimal entry barrier: Say goodbye to complex brokerage account opening and compliance procedures. Simply use your existing crypto assets (e.g., USDT) as margin to access global equities seamlessly. 2. 24/7 trading: Markets are open around the clock. Even when U.S. stock markets are closed, tokenized assets allow you to capture volatility driven by global macro events or earnings reports during pre-market, after-hours, and holidays. 3. Maximized capital efficiency: Enjoy leverage of up to 100x. With a unified trading account, a single margin balance can be used across spot, futures, and stock products, improving capital efficiency and flexibility. 4. Strong market position: According to the latest data, Bitget accounts for approximately 89% of global trading volume in stock tokens issued by platforms such as Ondo Finance, making it one of the most liquid platforms in the real-world asset (RWA) sector. 5. Multi-layered, institutional-grade security: Bitget publishes monthly Proof of Reserves (PoR), with an overall reserve ratio consistently exceeding 100%. A dedicated user protection fund is maintained at over $300 million, funded entirely by Bitget's own capital. Designed to compensate users in the event of hacks or unforeseen security incidents, it is one of the largest protection funds in the industry. The platform uses a segregated hot and cold wallet structure with multi-signature authorization. Most user assets are stored in offline cold wallets, reducing exposure to network-based attacks. Bitget also holds regulatory licenses across multiple jurisdictions and partners with leading security firms such as CertiK for in-depth audits. Powered by a transparent operating model and robust risk management, Bitget has earned a high level of trust from over 120 million users worldwide. By trading on Bitget, you gain access to a world-class platform with reserve transparency that exceeds industry standards, a protection fund of over $300 million, and institutional-grade cold storage that safeguards user assets—allowing you to capture opportunities across both U.S. equities and crypto markets with confidence.

MTVA stock overview